<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: AstraZeneca posts very respectable first half results	</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/astrazeneca-posts-very-respectable-first-half-results/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/astrazeneca-posts-very-respectable-first-half-results/</link>
	<description></description>
	<lastBuildDate>Sun, 28 Jul 2024 18:28:10 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.3</generator>
	<item>
		<title>
		By: temp mail number		</title>
		<link>https://ukinvestor.foxrobinson.com/astrazeneca-posts-very-respectable-first-half-results/#comment-29925</link>

		<dc:creator><![CDATA[temp mail number]]></dc:creator>
		<pubDate>Sun, 28 Jul 2024 18:28:10 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=74324#comment-29925</guid>

					<description><![CDATA[&lt;a href=&quot;https://sesox.xyz/&quot; rel=&quot;nofollow ugc&quot;&gt;Temp Mail&lt;/a&gt; This is my first time pay a quick visit at here and i am really happy to read everthing at one place]]></description>
			<content:encoded><![CDATA[<p><a href="https://sesox.xyz/" rel="nofollow ugc">Temp Mail</a> This is my first time pay a quick visit at here and i am really happy to read everthing at one place</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: insightsway		</title>
		<link>https://ukinvestor.foxrobinson.com/astrazeneca-posts-very-respectable-first-half-results/#comment-29896</link>

		<dc:creator><![CDATA[insightsway]]></dc:creator>
		<pubDate>Sat, 27 Jul 2024 10:35:47 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=74324#comment-29896</guid>

					<description><![CDATA[Thanks I have just been looking for information about this subject for a long time and yours is the best Ive discovered till now However what in regards to the bottom line Are you certain in regards to the supply]]></description>
			<content:encoded><![CDATA[<p>Thanks I have just been looking for information about this subject for a long time and yours is the best Ive discovered till now However what in regards to the bottom line Are you certain in regards to the supply</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: blogmedia		</title>
		<link>https://ukinvestor.foxrobinson.com/astrazeneca-posts-very-respectable-first-half-results/#comment-29858</link>

		<dc:creator><![CDATA[blogmedia]]></dc:creator>
		<pubDate>Thu, 25 Jul 2024 15:04:58 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=74324#comment-29858</guid>

					<description><![CDATA[I loved as much as youll receive carried out right here The sketch is attractive your authored material stylish nonetheless you command get bought an nervousness over that you wish be delivering the following unwell unquestionably come more formerly again as exactly the same nearly a lot often inside case you shield this hike]]></description>
			<content:encoded><![CDATA[<p>I loved as much as youll receive carried out right here The sketch is attractive your authored material stylish nonetheless you command get bought an nervousness over that you wish be delivering the following unwell unquestionably come more formerly again as exactly the same nearly a lot often inside case you shield this hike</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
